Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors

Lignende værker

• Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
  af: Oh, Felix, et al.
  Udgivet: (2018)
• Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
  af: Borgatti, Antonella, et al.
  Udgivet: (2017)
• A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature
  af: Tsai, Alexander K., et al.
  Udgivet: (2010)
• Bispecific Targeting of EGFR and uPAR in a Mouse Model of Head and Neck Squamous Cell Carcinoma
  af: Waldron, Nate N., et al.
  Udgivet: (2012)
• Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR
  af: Degryse, Bernard, et al.
  Udgivet: (2017)